New antibody boosts immune response against blood cancers and solid cancers

In a recent preclinical study, researchers from The University of Texas MD Anderson Cancer Center developed an antibody therapy called 77A that showed an ability to overcome treatment resistance in blood cancers, such as myeloma and lymphoma, as…

Continue Reading

News Source: medicalxpress.com